Insider Selling: Billiontoone (NASDAQ:BLLN) CEO Sells 24,999 Shares of Stock

Billiontoone, Inc. (NASDAQ:BLLN) CEO Oguzhan Atay sold 24,999 shares of Billiontoone stock in a transaction on Monday, September 14th. The shares were sold at an average price of $100.32, for a total value of $2,507,899.68. Following the sale, the chief executive officer directly owned 16,666 shares in the company, valued at $1,671,933.12. The trade was a 60.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Oguzhan Atay also recently made the following trade(s):

• On Monday, September 14th, Oguzhan Atay sold 5,332 shares of Billiontoone stock. The stock was sold at an average price of $98.00, for a total value of $522,536.00.
• On Monday, August 3rd, Oguzhan Atay sold 12,500 shares of Billiontoone stock. The shares were sold at an average price of $137.37, for a total value of $1,717,125.00.
• On Monday, August 3rd, Oguzhan Atay sold 32,500 shares of Billiontoone stock. The shares were sold at an average price of $136.95, for a total transaction of $4,450,875.00.
• On Thursday, July 9th, Oguzhan Atay sold 12,500 shares of Billiontoone stock. The stock was sold at an average price of $126.10, for a total transaction of $1,576,250.00.
• On Monday, July 6th, Oguzhan Atay sold 12,500 shares of Billiontoone stock. The shares were sold at an average price of $122.05, for a total transaction of $1,525,625.00.
• On Monday, July 6th, Oguzhan Atay sold 26,250 shares of Billiontoone stock. The shares were sold at an average price of $122.05, for a total transaction of $3,203,812.50.

Billiontoone Price Performance

Billiontoone stock traded down $0.66 during trading hours on Wednesday, hitting $103.61. 398,500 shares of the company traded hands, compared to its average volume of 540,867. Billiontoone, Inc. has a 1-year low of $61.96 and a 1-year high of $150.44. The firm has a market cap of $4.89 billion and a P/E ratio of 148.01. The firm’s 50-day simple moving average is $110.91 and its two-hundred day simple moving average is $96.44. The company has a quick ratio of 11.31, a current ratio of 11.69 and a debt-to-equity ratio of 0.17.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.15. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. The company had revenue of $109.45 million during the quarter. As a group, analysts forecast that Billiontoone, Inc. will post 0.83 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on BLLN shares. Wall Street Zen lowered Billiontoone from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. JPMorgan Chase & Co. dropped their price objective on Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a research note on Thursday, August 6th. Canaccord Genuity Group began coverage on Billiontoone in a report on Wednesday, September 2nd. They issued a “buy” rating and a $120.00 price objective for the company. BTIG Research lowered their target price on Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a report on Thursday, August 6th. Finally, Weiss Ratings upgraded shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, June 23rd. Seven equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $125.88.

Institutional Trading of Billiontoone

Large investors have recently added to or reduced their stakes in the business. Adams Street Partners LLC acquired a new position in shares of Billiontoone in the 4th quarter worth $140,063,000. Wasatch Advisors LP acquired a new position in shares of Billiontoone in the 1st quarter valued at $29,179,000. Capital International Investors acquired a new position in shares of Billiontoone in the 4th quarter valued at $14,568,000. Renaissance Technologies LLC purchased a new position in Billiontoone in the 1st quarter worth about $4,046,000. Finally, Emerald Advisers LLC increased its stake in Billiontoone by 26.8% in the 1st quarter. Emerald Advisers LLC now owns 239,562 shares of the company’s stock worth $18,911,000 after purchasing an additional 50,613 shares in the last quarter.

About Billiontoone

BillionToOne, Inc is a molecular diagnostics company that develops blood-based tests designed to provide genetic and health information from small amounts of biological material. The company’s technology uses its proprietary quantitative counting template approach to improve the accuracy and sensitivity of molecular testing.

The company’s primary offerings include UNITY, a portfolio of prenatal genetic tests. These services support screening for chromosomal conditions, single-gene disorders and carrier status, and are designed to help healthcare providers assess fetal and maternal genetic risks using a maternal blood sample.